Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report)’s share price shot up 4.2% during mid-day trading on Monday. The stock traded as high as $8.86 and last traded at $8.75. Approximately 8,742 shares were traded during trading, a decline of 91% from the average daily volume of 98,363 shares. The stock had previously closed at $8.40.
Revolution Medicines Stock Performance
The stock has a 50 day moving average price of $11.05 and a 200 day moving average price of $8.30.
Revolution Medicines Company Profile
Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer. The company’s research is centered on the RAS signaling pathway, which is frequently altered in tumors and has historically been difficult to target with medicines.
Revolution Medicines is developing a pipeline of RAS(ON) inhibitors designed to block active RAS proteins and related signaling. Its investigational programs include daraxonrasib (RMC-6236), an oral, broad-spectrum RAS(ON) inhibitor, as well as mutation-selective candidates such as RMC-9805 for KRAS G12D and RMC-6291 for KRAS G12C.
Further Reading
- Five stocks we like better than Revolution Medicines
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
